Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults

A live attenuated zoster vaccine (ZOSTAVAX™, Merck & Co., Inc.) was approved by the Korea Ministry of Food and Drug Safety in 2009. However, the immunogenicity and safety of the vaccine has not been assessed in Korean population. This is multi-center, open-label, single-arm study performed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Won Suk, Choi, Jung-Hyun, Choi, Jun Yong, Eom, Joong Sik, Kim, Sang Il, Pai, Hyunjoo, Peck, Kyong Ran, Sohn, Jang Wook, Cheong, Hee Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712571/
https://www.ncbi.nlm.nih.gov/pubmed/26770032
http://dx.doi.org/10.3346/jkms.2016.31.1.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712571/
https://www.ncbi.nlm.nih.gov/pubmed/26770032
http://dx.doi.org/10.3346/jkms.2016.31.1.13

Ejemplares similares